Cryo Rib Fracture Study

Part of paid clinical trials in Minneapolis, Minnesota.

Sponsor
University of Minnesota
Study ID
NCT06347874
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Rib Fractures

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Cryoablation — DRUG
    an injection of 1ml of 1% lidocaine per rib and ultrasound guided cryoablation of the intercostal nerves
  • ESP Catheter — DRUG
    an ultrasound guided erector spinae plane catheter with initial bolus of 30 mL of 0.25% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour via programmed intermittent bolus.

Study Details

The purpose of this study is to determine if patients with rib fractures who undergo cryoablation of the intercostal nerves have improved pain control 7 days from procedure when compared to those who have a ESP catheter.

Key Dates

Start date
Jan 10, 2025
Status verified
Feb 2026
Primary completion
Feb 13, 2027
Completion
Mar 13, 2027

Study Design

Enrollment
48 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Cryoablation
    Participants with rib fracture randomized to Cryoablation.
  • Active Comparator: ESP catheter
    Participants with rib fracture randomized to ESP Catheter.

Primary Outcome Measure

Maximum pain score on POD (Post Operative Day) 7 [ Time Frame: 7 days post procedure ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of MinnesotaMinneapolisMinnesota55414
Allicia Bulleri

Find similar trials in Minneapolis, MN

By research site
University of Minnesota· Minneapolis, MN

Related Studies